# Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer

> **NCT00780169** · PHASE1 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 16 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** sorafenib + FOLFIRI

## Key facts

- **NCT ID:** NCT00780169
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-05
- **Final completion:** 2012-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00780169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00780169, "Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00780169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*